Establishment and characterization of androgen‐independent human prostate cancer LNCaP cell model
T Igawa, FF Lin, MS Lee, D Karan, SK Batra… - The Prostate, 2002 - Wiley Online Library
BACKGROUND The acquisition of an androgen‐independent phenotype is the most serious
issue of prostate cancer treatment. Although several experimental cell models have been …
issue of prostate cancer treatment. Although several experimental cell models have been …
LNCaP progression model of human prostate cancer: Androgen‐independence and osseous metastasis
GN Thalmann, RA Sikes, TT Wu, A Degeorges… - The …, 2000 - Wiley Online Library
BACKGROUND Clinically, the lethal phenotypes of human prostate cancer are
characterized by their progression to androgen‐independence and their propensity to form …
characterized by their progression to androgen‐independence and their propensity to form …
Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells
D Karan, DL Kelly, A Rizzino, MF Lin… - Carcinogenesis, 2002 - academic.oup.com
Because of the heterogeneous nature of prostate cancer, identifying the molecular
mechanisms involved during the transition from an androgen-sensitive to an androgen …
mechanisms involved during the transition from an androgen-sensitive to an androgen …
Molecular alterations associated with LNCaP cell progression to androgen independence
XB Shi, AH Ma, CG Tepper, L Xia, JP Gregg… - The …, 2004 - Wiley Online Library
BACKGROUND There is no effective therapy currently available for androgen‐independent
(AI) prostate cancer (CaP). This is largely due to lack of information about the molecular …
(AI) prostate cancer (CaP). This is largely due to lack of information about the molecular …
Variants of the human prostate LNCaP cell line as tools to study discrete components of the androgen-mediated proliferative response.
Androgens regulate the proliferation of their target cells through a sequential two-step
mechanism. In the first step, androgens increase proliferation rates; following this …
mechanism. In the first step, androgens increase proliferation rates; following this …
Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not …
CL Tso, WH McBride, J Sun, B Patel… - Cancer Journal …, 2000 - europepmc.org
Purpose The mechanism of progression of human prostate cancer (CaP) cells under
androgen ablation therapy remains unclear. To study the alternative pathways of CaP cell …
androgen ablation therapy remains unclear. To study the alternative pathways of CaP cell …
Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence
E Unni, S Sun, B Nan, MJ McPhaul, B Cheskis… - Cancer research, 2004 - AACR
A cure for prostate cancer (CaP) will be possible only after a complete understanding of the
mechanisms causing this disease to progress from androgen dependence to androgen …
mechanisms causing this disease to progress from androgen dependence to androgen …
Molecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells
S Lu, SY Tsai, MJ Tsai - Endocrinology, 1999 - academic.oup.com
The goal of this study is to investigate the molecular mechanisms of androgen-independent
growth in prostate cancer. We have established an androgen-independent prostatic …
growth in prostate cancer. We have established an androgen-independent prostatic …
Progression to androgen‐independent LNCaP human prostate tumors: cellular and molecular alterations
Lethal phenotypes of human prostate cancer are characterized by progression to androgen‐
independence and metastasis. For want of a clinically relevant animal model, mechanisms …
independence and metastasis. For want of a clinically relevant animal model, mechanisms …
Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens
KK Waltering, MA Helenius, B Sahu, V Manni, MJ Linja… - Cancer research, 2009 - AACR
Androgen receptor (AR) is known to be overexpressed in castration-resistant prostate
cancer. To interrogate the functional significance of the AR level, we established two LNCaP …
cancer. To interrogate the functional significance of the AR level, we established two LNCaP …